Evaluation of automated serum des-gamma-carboxyprothrombin (DCP) assays for detecting hepatocellular carcinoma (Q53089221)

11 May 2018

title

Evaluation of automated serum des-gamma-carboxyprothrombin (DCP) assays for detecting hepatocellular carcinoma (English)

1 reference

https://api.crossref.org/works/10.1016/J.CLINBIOCHEM.2011.08.1144

13 December 2024

0 references

2

Yongjung Park

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21939644

13 December 2024

author name string

Jonghyeon Choi

1

1 reference

11 May 2018

Jeong-Ho Kim

3

1 reference

11 May 2018

Hyon-Suk Kim

4

1 reference

11 May 2018

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21939644

13 December 2024

publication date

12 September 2011

1 reference

11 May 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S0009912011026324?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.CLINBIOCHEM.2011.08.1144

https://api.elsevier.com/content/article/PII:S0009912011026324?httpAccept=text/plain

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINBIOCHEM.2011.08.1144

13 December 2024

published in

Clinical Biochemistry

1 reference

11 May 2018

volume

44

1 reference

11 May 2018

issue

17-18

1 reference

11 May 2018

page(s)

1464-1468

1 reference

11 May 2018

Abnormal prothrombin in the vitamin K-deficient rat

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.CLINBIOCHEM.2011.08.1144

Vitamin K-dependent carboxylation

13 December 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.CLINBIOCHEM.2011.08.1144

Mechanism of the abnormal vitamin K-dependent gamma-carboxylation process in human hepatocellular carcinomas

13 December 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.CLINBIOCHEM.2011.08.1144

PIVKA-II during perioperative period in patients with hepato-biliary-pancreatic diseases

13 December 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.CLINBIOCHEM.2011.08.1144

Clinical evaluation of plasma des-gamma-carboxy prothrombin as a marker protein of hepatocellular carcinoma in patients with tumors of various sizes

13 December 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.CLINBIOCHEM.2011.08.1144

Des-gamma-carboxy prothrombin and proliferative activity of hepatocellular carcinoma

13 December 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.CLINBIOCHEM.2011.08.1144

The role of tumor markers in the diagnosis of hepatocellular carcinoma, with special reference to the des-gamma-carboxy prothrombin

13 December 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.CLINBIOCHEM.2011.08.1144

Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma

13 December 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.CLINBIOCHEM.2011.08.1144

Usefulness of serum des-gamma-carboxy prothrombin in detection of hepatocellular carcinoma

13 December 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.CLINBIOCHEM.2011.08.1144

PIVKA-II is a useful tumor marker for recurrent hepatocellular carcinoma after surgical resection.

13 December 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.CLINBIOCHEM.2011.08.1144

A comparative evaluation of Golgi protein-73, fucosylated hemopexin, α-fetoprotein, and PIVKA-II in the serum of patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma

13 December 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.CLINBIOCHEM.2011.08.1144

The role of des-gamma-carboxy prothrombin levels in hepatocellular carcinoma and liver tissues.

13 December 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.CLINBIOCHEM.2011.08.1144

Clinical significance of abnormal prothrombin (DCP) in relation to postoperative survival and prognosis in patients with hepatocellular carcinoma

13 December 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.CLINBIOCHEM.2011.08.1144

Serum and tissue PIVKA-II expression reflect the biological malignant potential of small hepatocellular carcinoma

13 December 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.CLINBIOCHEM.2011.08.1144

Prognostic significance of simultaneous measurement of three tumor markers in patients with hepatocellular carcinoma

13 December 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.CLINBIOCHEM.2011.08.1144

Clinical and molecular insights into the hepatocellular carcinoma tumour marker des‐γ‐carboxyprothrombin

13 December 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.CLINBIOCHEM.2011.08.1144

Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic review.

13 December 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.CLINBIOCHEM.2011.08.1144

Serum des-gamma-carboxy prothrombin levels determined by a new generation of sensitive immunoassays in patients with small-sized hepatocellular carcinoma

13 December 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.CLINBIOCHEM.2011.08.1144

Clinical utility of simultaneous measurement of serum high-sensitivity des-gamma-carboxy prothrombin and Lens culinaris agglutinin A-reactive alpha-fetoprotein in patients with small hepatocellular carcinoma

13 December 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.CLINBIOCHEM.2011.08.1144

Liquid-phase binding assay of alpha-fetoprotein using DNA-coupled antibody and capillary chip electrophoresis

13 December 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.CLINBIOCHEM.2011.08.1144

Automated immunoassay system for AFP-L3% using on-chip electrokinetic reaction and separation by affinity electrophoresis

13 December 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.CLINBIOCHEM.2011.08.1144

Des-gamma-carboxy prothrombin (DCP) ratio, a novel parameter measured by monoclonal antibodies MU-3 and 19B7, as a new prognostic indicator for hepatocellular carcinoma

13 December 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.CLINBIOCHEM.2011.08.1144

Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients

13 December 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.CLINBIOCHEM.2011.08.1144

Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population

13 December 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.CLINBIOCHEM.2011.08.1144

Elevations in serum alpha-fetoprotein levels in patients with chronic hepatitis B.

13 December 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.CLINBIOCHEM.2011.08.1144

Plasma des-gamma-carboxyprothrombin in the early stage of hepatocellular carcinoma

13 December 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.CLINBIOCHEM.2011.08.1144

Hepatocellular carcinoma in Italian patients with cirrhosis

13 December 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.CLINBIOCHEM.2011.08.1144

Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis

13 December 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.CLINBIOCHEM.2011.08.1144

Time courses of PIVKA-II and AFP levels after hepatic artery embolization and hepatic artery infusion against hepatocellular carcinoma: relation between the time course and tumor necrosis

13 December 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.CLINBIOCHEM.2011.08.1144

13 December 2024

Identifiers

1 reference

11 May 2018

1 reference

11 May 2018